| |
| |
|
| Insider
Information: |
Hobbs Eamonn P |
| Relationship: |
Director |
| City: |
Queensbury |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
779,166 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,524,792 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
779,166 |
|
|
| Total
Value |
$4,524,792 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
E-Z-EM Inc |
EZEM |
Senior VP - AngioDynam... |
2004-04-21 |
10,059 |
2004-04-13 |
0 |
Premium* |
|
|
Angiodynamics Inc |
ANGO |
President & CEO, Direc... |
2009-02-13 |
100,401 |
2004-10-30 |
0 |
Premium* |
|
|
Delcath Systems Inc |
DCTH |
President and CEO, Dir... |
2012-06-01 |
162,000 |
2009-11-18 |
0 |
Premium* |
|
|
Antares Pharma Inc |
ATRS |
President & CEO, Direc... |
2018-05-28 |
445,254 |
2009-12-15 |
0 |
Premium* |
|
|
Orasure Technologies Inc |
OSUR |
Director |
2022-05-16 |
61,452 |
2016-05-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
100 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANGO |
Angiodynamics Inc |
President & CEO |
• • – |
2006-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,062 |
62,176 |
|
- |
|
| ANGO |
Angiodynamics Inc |
President & CEO |
• • – |
2007-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,031 |
82,571 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
President & CEO |
• • – |
2008-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,031 |
87,257 |
0 |
- |
|
| DCTH |
Delcath Systems Inc |
President and CEO |
• • – |
2011-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
125,000 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2011-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
28,012 |
48,012 |
0 |
- |
|
| DCTH |
Delcath Systems Inc |
President and CEO |
• • – |
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
155,000 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2013-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
27,778 |
122,860 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
President and CEO |
• • – |
2014-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
274,086 |
373,446 |
0 |
- |
|
| OSUR |
Orasure Technologies Inc |
Director |
– • – |
2016-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
11,700 |
11,700 |
0 |
- |
|
| OSUR |
Orasure Technologies Inc |
Director |
– • – |
2017-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,295 |
14,711 |
0 |
- |
|
| OSUR |
Orasure Technologies Inc |
Director |
– • – |
2018-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,144 |
20,855 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
President & CEO |
• • – |
2018-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
245,532 |
445,254 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
President & CEO |
• • – |
2006-04-07 |
4 |
OE |
$4.35 |
$2,174 |
D/D |
500 |
43,389 |
|
- |
|
| EZEM |
E-Z-EM Inc |
Senior VP - AngioDynamics |
• – – |
2004-04-14 |
4 |
OE |
$4.22 |
$5,486 |
D/D |
1,300 |
1,359 |
|
- |
|
| ANGO |
Angiodynamics Inc |
officerTitle |
• • – |
2006-01-06 |
4 |
OE |
$4.35 |
$8,696 |
D/D |
2,000 |
15,789 |
|
- |
|
| DCTH |
Delcath Systems Inc |
President and CEO |
• • – |
2012-06-01 |
4 |
B |
$1.52 |
$10,611 |
D/D |
7,000 |
162,000 |
2.81 |
- |
|
| OSUR |
Orasure Technologies Inc |
Director |
– • – |
2022-05-16 |
4 |
D |
$5.25 |
$12,647 |
D/D |
(2,409) |
41,452 |
0 |
- |
|
| OSUR |
Orasure Technologies Inc |
Director |
– • – |
2019-05-06 |
4 |
D |
$9.88 |
$13,351 |
D/D |
(1,351) |
18,120 |
0 |
- |
|
| OSUR |
Orasure Technologies Inc |
Director |
– • – |
2021-05-17 |
4 |
D |
$9.50 |
$13,739 |
D/D |
(1,446) |
32,909 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
President & CEO |
• • – |
2006-04-07 |
4 |
AS |
$30.02 |
$15,010 |
D/D |
(500) |
42,889 |
|
- |
|
| ANGO |
Angiodynamics Inc |
President & CEO |
• • – |
2006-04-24 |
4 |
OE |
$4.35 |
$17,391 |
D/D |
4,000 |
46,889 |
|
- |
|
| ANGO |
Angiodynamics Inc |
President & CEO |
• • – |
2006-11-01 |
4 |
OE |
$4.35 |
$17,748 |
D/D |
4,082 |
76,258 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
President and CEO |
• • – |
2014-09-10 |
4 |
B |
$2.20 |
$19,800 |
D/D |
9,000 |
382,446 |
2.81 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2009-12-15 |
4 |
B |
$1.07 |
$21,400 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| ANGO |
Angiodynamics Inc |
President & CEO |
• • – |
2004-10-30 |
4 |
A |
$9.72 |
$21,627 |
D/D |
2,225 |
10,839 |
|
- |
|
100 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
